The company has completed paying off a $600,000 settlement agreement for using Health Discovery Corporation's SVM IP for protein biomarker discovery.
The settlement will end a dispute dating back more than two years and likely help CombiMatrix as it continues to seek "strategic options" for the company.
The agreement to issue additional shares settles claims brought against Sequenom for alleged breach of representations and warranties made by Sequenom in its asset purchase agreement.
The settlement ends a one-year-old dispute regarding mass-spec based patents held by Sequenom.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.